Technical Analysis for LABP - Landos Biopharma, Inc.

Grade Last Price % Change Price Change
D 10.78 -2.36% -0.26
LABP closed up 1.28 percent on Friday, July 23, 2021, on 76 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Up
Historical LABP trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish -2.36%
Calm After Storm Range Contraction -2.36%
Fell Below 20 DMA Bearish -1.10%
Calm After Storm Range Contraction -1.10%
Down 3 Days in a Row Weakness -1.10%
20 DMA Support Bullish -1.91%
MACD Bullish Signal Line Cross Bullish -1.91%
Calm After Storm Range Contraction -1.91%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.88%
20 DMA Support Bullish -2.88%
Older End-of-Day Signals for LABP ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
20 DMA Resistance 5 minutes ago
Gapped Down (Partial) 5 minutes ago
Down 3% 19 minutes ago
Down 2 % 19 minutes ago
Down 1% 19 minutes ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. Its lead product candidate in development is BT-11, an oral lanthionine synthetase C-like protein 2 (LANCL2) agonist for the treatment of ulcerative colitis (UC), Crohn's disease (CD), and inflammatory bowel diseases. The company also develops NX-13, a gut-restricted oral therapeutic that targets NOD-like receptor X1, a mitochondria-associated receptor associated with the modulation of inflammatory cytokines for UC and CD; and PX-69, an oral PLXDC2 agonist for the treatment of diabetic nephropathy and rheumatoid arthritis. The company was founded in 2017 and is headquartered in Blacksburg, Virginia.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Autoimmune Diseases Rheumatoid Arthritis Inflammatory Bowel Disease Gastroenterology Colitis Ulcerative Colitis Abdominal Pain Diarrhea Crohn's Disease Diabetic Nephropathy Inflammatory Bowel Diseases

Is LABP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 16.989
52 Week Low 8.84
Average Volume 46,285
200-Day Moving Average 0.00
50-Day Moving Average 11.32
20-Day Moving Average 10.94
10-Day Moving Average 10.55
Average True Range 0.64
ADX 14.16
+DI 19.76
-DI 22.22
Chandelier Exit (Long, 3 ATRs) 10.31
Chandelier Exit (Short, 3 ATRs) 11.42
Upper Bollinger Bands 12.14
Lower Bollinger Band 9.75
Percent B (%b) 0.54
BandWidth 21.86
MACD Line -0.17
MACD Signal Line -0.23
MACD Histogram 0.0622
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.90
Resistance 3 (R3) 11.82 11.46 11.76
Resistance 2 (R2) 11.46 11.24 11.50 11.71
Resistance 1 (R1) 11.25 11.10 11.35 11.33 11.66
Pivot Point 10.88 10.88 10.93 10.92 10.88
Support 1 (S1) 10.67 10.66 10.78 10.75 10.42
Support 2 (S2) 10.31 10.53 10.35 10.37
Support 3 (S3) 10.10 10.31 10.32
Support 4 (S4) 10.18